Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy

Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy

US Patent 10279014 · Granted May 7, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tailored hypoimmune nanovesicular delivery systems for cancer tumors2025
Smart multidosing2025
Smart dosing for cancer therapy2025
Smart multidosing2025
Methods and compositions for RNA-guided treatment of HIV infection2025
Smart nutrition dosing2025
Excision of retroviral nucleic acid sequences2024
Smart dosing for cancer therapy2024
BAG3 as a target for therapy of heart failure2023
Gene editing methods and compositions for eliminating risk of JC virus activatio2022
Gene editing methods and compositions for eliminating risk of JC virus activatio2022
Gene editing methods and compositions for eliminating risk of JC virus activatio2022